CytomX Announces Year-End 2015 Financial Results
Mar 07, 2016 13:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 07, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today reported year-end...
Mar 07, 2016 13:03 pm UTC| Business
WILMINGTON, Del., March 07, 2016 -- Andrews Springer LLC,a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against...
Nano One Approved for $2 Million SDTC Grant
Mar 07, 2016 13:02 pm UTC| Business
VANCOUVER, British Columbia, March 07, 2016 -- Nano One Materials Corp. (“Nano One”) (TSX.V:NNO) is pleased to announce that it has been approved for a $2.08 million technology commercialization grant from Sustainable...
William E. Connor & Associates Named One of World’s Most Ethical Companies for Fifth Year in a Row
Mar 07, 2016 13:00 pm UTC| Business
HONG KONG, March 07, 2016 -- William E. Connor Associates Ltd. announced today that it has been recognized by the Ethisphere Institute, the leading U.S. business ethics think-tank, as a 2016 World’s Most Ethical...
Celebrate Pi Day @ Bojangles’®, Get 3 Baked Sweet Potato Pies for $3.14
Mar 07, 2016 13:00 pm UTC| Business
CHARLOTTE, N.C., March 07, 2016 -- National Pi Day is around the corner, and while Bojangles’ (NASDAQ:BOJA) famous Sweet Potato Pie isn’t actually circular in shape, it’s still perfect for celebrating this awesome...
Sensata Technologies and Quanergy Systems Announce Strategic Partnership
Mar 07, 2016 13:00 pm UTC| Business
ALMELO, the Netherlands and SUNNYVALE, Calif., March 07, 2016 -- Sensata Technologies Holding N.V. (NYSE:ST), a leading manufacturer of sensing, electrical protection, control and power management solutions, and...
BeiGene Receives Approval to Initiate Clinical Trials in China With BGB-3111
Mar 07, 2016 13:00 pm UTC| Business
BEIJING, March 07, 2016 -- BeiGene, Ltd. (Nasdaq:BGNE), (“BeiGene”) a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncological drugs for the treatment of cancer, today...